You are on page 1of 101

| 



|

     

V Hypertension
Etiology and Pathophysiology
 Hypertension increases the risk of coronary artery
disease, heart failure, MI, CVA and renal failure
 Risk Factors include: Stress, obesity, nutrition (high
Na, low Ca, Mg and K), substance abuse (cigarettes,
alcohol, cocaine), Family history, age, sedantary
lifestyle, hyperlipidemia.
 Often asymptomatic; Dx requires three assessments

of elevated BP on separate occassions.


V Hypertension
Etiology and Pathophysiology
 Classification of BP
 Optimal: systolic <129mm Hg; diastolic <80 mm Hg
 Normal: systolic <130mm Hg; diastolic <85mm Hg
 High normal: systolic 130 to 139 mm Hg; diastolic 85 to 89
mm Hg
 Hypertension: stage 1: systolic 140 to 159 mm Hg, diastolic
90 to 99 mm Hg; stage 2: systolic 160 to 179 mm Hg,
diastolic 100 to 109 mm Hg; stage 3: systolic 180 mm Hg,
diastolic 110 mm Hg
V Hypertension
Etiology and Pathophysiology
 Primary (essential) hypertension
 90 to 95% of all cases of hypertension

 Etiology is complex; begins insidiuosly; changes in


arteriolar bed cause increased resistance; increased
blood volume may result from hormonal or renal
dysfunction; arteriolar thickening causes increased
resistance; increased blood volume may result from
hormonal or renal dysfunction; arteriolar thickening
causes increased peripheral vascular resistance;
anbormal renin release constricts arterioles.
V Hypertension
Etiology and Pathophysiology
 Secondary hypertension
 Results from renovascular disease;
hyperaldosteronism; Cushingǯs syndrome; DM;
dysfunction of thyroid, pituitary or parathyroid
glands; coarctation of the aorta and pregnancy.
V Hypertension
Clinical Findings:
 Subjective: headache (occipital area);
lightheadedness; tinnitus; easy fatigue; visual
disturbances; palpitations.
 Objective: BP greater than 140/90 mm Hg obtained

on 3 separate occasions; retinal changes; renal


pathology (azotemia); epistaxis; cardiac
hypertrophy.
V Hypertension
Therapeutic Interventions
 Lifestyle modifications; sodium restriction (1 to 2 g
daily); weight control or reduction; alcohol
restriction; cessation of smoking; regular exercise
program ; stress management.
 Diuretics, Beta blocker, calcium antagonist, ACE
inhibitors is prescribed based on clientǯs other
health problems.
V Hypertension
Therapeutic Interventions
 If ineffective, the dosage of the drug is increased, a
different drug is given or a second drug of a different
classification is added.
 If still ineffective a second drug is substituted or a

third drug of a different classification is added.


 If still ineffective a third or fourth drug is added.

 Relaxation modalities such as biofeedback and

guided imagery.
V Hypertension
Nursing care of client with HPN
Assessment:
 VS with client in both upright and recumbent
positions; baseline weight; presence of risk factors
and clinical findings.
Nursing diagnoses
 Imbalanced nutrition: more than body requirements
r/t lack of knowledge of relationship between diet
and disease process
V Hypertension
Nursing diagnosis
 Ineffective health maintenance r/t deficient
knowledge regarding treatment and control of
disease process
 Fear r/t questionable prognosis and potential

disability or death
V Hypertension
Planning/ Implementation
 Monitor electrolytes, BUN, creatinine, lipid profile
and proteinuria
 Weigh client daily when there is threat of heart
failure
 Teach client to monitor own BP; advise client to
change position slowly and avoid hot showers to
prevent orthostatic hypotension
 Reinforce that hypertension is not cured but
controlled
V Hypertension
Planning/ Implementation
 Reassure and support any expression of emotions;
encourage relaxation techniques.
 Educate the client and family regarding drugs, follow
up care, activity restrictions and diet.
V Coronary Artery Disease (CAD): Atherosclerosis,
Angina Pectoris, Myocardial Infarction
Etiology and Pathophysiology
 Atherosclerosis: deposition of fatty plaques along
inner wall of coronary arteries leads to smooth
muscle cell proliferation, narrowing and possible
obstruction; also affects peripheral and cerebral
vessels.
 Angina pectoris: episodic pain experienced when
oxygen supplied by the blood cannot meet the
metabolic demands of the muscle.
V TYPES OF ANGINA PECTORIS

V Stable Angina
Chest pain lasts for less than 15 minutes
Recurrence is less frequent

V Unstable Angina (Preinfarction Angina, Crescendo Angina,


Intermittent Coronary Syndrome)
Chest pain last for more than 15 minutes but less than 30 minutes
Recurrence is more frequent, may occur at night
Intensity of pain increases

V Variant Angina (Prinzmetalǯs Angina)


Chest pain is of longer duration and may occur at rest
The attacks tend to occur in the early hours of the day
May result from coronary artery spasm
V Nocturnal Angina
Occurs only during the night and is possibly associated
with rapid eye movement (REM) sleep

V Angina Decubitus
Paroxysmal chest pain that occurs when the client sits
or stands up

V Intractable Angina
Chronic, incapacitating angina unresponsive to
intervention

V Postinfarction Angina
Occurs after MI, when residual ischemia may cause
episodes of angina
V Coronary Artery Disease (CAD): Atherosclerosis,
Angina Pectoris, Myocardial Infarction
Etiology and Pathophysiology
 Myocardial infarction (MI): Acute necrosis of the
heart muscle caused by interruption of O2 supply to
the are, resulting in altered function and reduced
cardiac output.
V Coronary Artery Disease (CAD): Atherosclerosis,
Angina Pectoris, Myocardial Infarction
Etiology and Pathophysiology
 Risk factors:
 Family history, increasing age, gender; males and females
especially after menopause, race: higher in african-
americans, cigarette smoking, hypertension,
hyperlipidemia, obesity, sedentary lifestyle, diabetes, stress
V Coronary Artery Disease (CAD): Atherosclerosis,
Angina Pectoris, Myocardial Infarction
Clinical Findings
 Subjective: retrosternal chest pain: pain may radiate
to arms, jaw, neck, shoulder or back; pain described
as Ǯpressureǯ, Ǯcrushingǯ or Ǯviselikeǯ; pain of angina is
associated with activity and generally subsides with
rest; palpitations; apprehension, feeling of dread;
dyspnea, nausea; asymptomatic with silent ischemia.
V Coronary Artery Disease (CAD): Atherosclerosis,
Angina Pectoris, Myocardial Infarction
Clinical Findings
 Objective:
 ECG changes may reveal ischemia (inverted T wave,
elevated ST segment) or evidence of MI (presence of Q
wave)
 Elevated serum enzymes and isoenzymes with MI: cardiac
troponin T levels increase within 3 to 6 hours and remain
elevated 14 to 21 days
 Cardiac troponin I levels rise 7 to 14 hours after an MI and
remain elevated for 5 to 7 days
V Coronary Artery Disease (CAD): Atherosclerosis,
Angina Pectoris, Myocardial Infarction
Clinical Findings
 Objective:
 Creatinine Kinase or Creatinine Phosphokinase elevated 3
to 6 hours after infarction, peaking at 24 hours and
returning to normal within 72 to 96 hours.
 CK-MB elevated 4 to 6 hours after pain, peaking within 24
hours
 LDH elevated on first day and reaches its peak on third to
fourth day
V Coronary Artery Disease (CAD): Atherosclerosis,
Angina Pectoris, Myocardial Infarction
Clinical Findings
 Objective:
 Aspartate aminotransferase (AST) elevated on days 2 to 4
V Coronary Artery Disease (CAD): Atherosclerosis,
Angina Pectoris, Myocardial Infarction
Therapeutic Interventions
 Prevention of MI:
 Supervised exercise program to avoid ischemia but
promote collateral circulation, increase HDL; weight
control; smoking cessation; dietary restriction of
cholesterol and saturated fat.
V Coronary Artery Disease (CAD): Atherosclerosis,
Angina Pectoris, Myocardial Infarction
Therapeutic Interventions
 Prevention of MI:
 Pharmacologic management; nitrates, beta-blocking
agents, calcium channel-blocking agents,
antilipidemics, antiplatelet agents.
 Supplemental oxygen during anginal attack as
needed
 PTCA

 CABG if medical regimen not successful


V Coronary Artery Disease (CAD): Atherosclerosis,
Angina Pectoris, Myocardial Infarction
Therapeutic Interventions
 Intracoronary stent placement

 Management of acute MI
 Improvement of perfusion: administer ASA
immediately en route to hospital; begin beta blockers
and IV nitroglycerin; thrombolytic therapy within 3
to 6 hours of MI; antidysrhythmics to maintain
cardiac function.
V Coronary Artery Disease (CAD): Atherosclerosis,
Angina Pectoris, Myocardial Infarction
Therapeutic Interventions
 Promotion of comfort and rest: administer analgesics
such as IV morphine sulfate; O2 administration to
alter tissue hypoxia; Maintain bed rest to decrease
oxygen tissue demands.
 Monitor client; pulse oximetry, cardiac monitoring,
VS monitoring
 Assessment for complications of MI: shock,
pulmonary edema, embolism, pericarditis
V Coronary Artery Disease (CAD): Atherosclerosis,
Angina Pectoris, Myocardial Infarction
Nursing care:
 Assessment: History of chest, arm, shoulder, neck,
jaw pain, precipitating factors, risk factors, vital
signs, intake and output, adventitious breath sounds
and dependent edema, restlessness, dyspnea,
diaphoresis, pallor, cyanosis, if MI is suspected
continuous ECG monitoring to detect changes in rate,
rhythm and conduction of heartbeat.
V Coronary Artery Disease (CAD): Atherosclerosis,
Angina Pectoris, Myocardial Infarction
Nursing care:
 Nursing Diagnoses:
 Acute pain r/t myocardial tissue damage from
inadequate blood supply
 Decreased cardiac output r/t ventricular damage,
ischemia, dysrhythmias
 Ineffective sexuality patterns r/t fear of chest pain,

possibility of heart damage


V Coronary Artery Disease (CAD): Atherosclerosis,
Angina Pectoris, Myocardial Infarction
Planning / Implementation:
 Teach signs and management of cardiac ischemia
(rest, nitrates, emergency care if needed)
 Encourage prophylactic administration of nitrates

 Reinforce need to avoid nonaerobic exertion and


exposure to cold air
 Low cholesterol, low fat diet; eat fish high in omega-

3 fatty acids, increase intake of high-fiber foods


V Coronary Artery Disease (CAD): Atherosclerosis,
Angina Pectoris, Myocardial Infarction
Planning / Implementation:
 Provide emotional support regarding alteration in
lifestyle
 Support involvement in smoking cessation programs
V Heart Failure
Etiology and Pathophysiology
 Inability of the heart to meet the demands of the
body.
 Pump failure may be caused by cardiac
abnormalities or conditions that place increased
demands on the heart such as cardiac muscle
disorders, valvular disorders, hypertension, coronary
atherosclerosis, hyperthyroidism, obesity
 When one side fails there is a buildup in the vascular

system feeding into that side.


V Heart Failure
Etiology and Pathophysiology
 Right ventricular failure will be evident in the
systemic circulation, those of left-ventricular failure
in the pulmonary system.
V Heart Failure
Clinical findings
 Left-sided failure
 Subjective: dyspnea from fluid within the lungs;

orthopnea; fatigue and restlessness


 Objective: crackles; peripheral cyanosis; frothy,
blood-tinged sputum; dry, non-productive cough
V Heart Failure
Clinical findings
 Right-sided failure
 Subjective: abdominal pain; fatigue; bloating; nausea

 Objective: dependent, pitting edema that often


subsides at night when legs are elevated; ankle
edema is frequently the first sign of HF; ascites;
hepatomegaly; anorexia; respiratory distress;
increased CVP; diminished urinary output.
V Heart Failure
Therapeutic interventions
 Rest in Fowlerǯs position to reduce cardiac workload
 Morphine SO4 to reduce anxiety and dyspnea

 O2 therapy; in acute ventricular failure endotracheal


intubation and a ventilator
 Decrease cardiac workload with diuretics, venous

vasodilators, vein and arteriole dilators, ACE


inhibitors and beta-adrenergic antagonists
 Increase pump performance with cardiac glycosides,
inotropes
V Heart Failure
Therapeutic interventions
 K-supplements to prevent digitalis toxicity and
hypokalemia
 Na-restricted diet to limit fluid retention and
promote fluid-excretion
 A paracentesis if ascites exists and is causing

respiratory distress
V Heart Failure
Nursing care
 Assessment:
 Baseline vital signs
 Body weight; circumference of edematous extremities
 Electrolyte levels (sodium, chloride, potassium)
 Intake and Output
V Heart Failure
Nursing care
 Diagnosis:
 Decreased cardiac outpit r/t impaired cardiac

function
 Excess fluid volume r/t impaired excretion of sodium
and water
 Impaired gas exchange r/t excessive fluid in
interstitial space
V Heart Failure
Planning/Implementation
 Maintain the client in HBR
 Elevate extremities except when the client is in acute

distress
 Frequently monitor VS

 Change positions frequently

 Monitor intake and output

 Restrict fluids as ordered


V Vascular disease: Thrombophlebitis, Varicose
veins and Peripheral Vascular Disease
Etiology and pathophysiology
 Thrombus: a clot composed of platelets, fibrin,
clotting factors and cellular debris attached to the
interior wall of an artery or vein
 Embolus: a clot or solid particle carried by the
bloodstream, which may interfere with tissue
perfusion in an artery or vein
V Vascular disease: Thrombophlebitis, Varicose
veins and Peripheral Vascular Disease
Etiology and pathophysiology
 Arterial disorders involve depriving oxygen to a body
part or tissue.
 Reduced blood flow resulting from atherosclerosis,
thrombus or embolus
 Buergerǯs disease (thromboangitis obliterans)
 Peripheral circulation impaired by inflammatory
occlusions of peripheral arteries
 Incidence is highest in young adult males who smoke
V Vascular disease: Thrombophlebitis, Varicose
veins and Peripheral Vascular Disease
Etiology and pathophysiology
 Arterial disorders involve depriving oxygen to a body
part or tissue.
 Raynaudǯs disease
 Spasms of digital arteries thought to be caused by
abnormal response of the SNS to cold or emotional
stress, usually bilateral and primarily occurs in young
females.
 Raynaudǯs phenomenon is episodic arterial spasm of
the extremities secondary to another disease or
abnormality
V Vascular disease: Thrombophlebitis, Varicose
veins and Peripheral Vascular Disease
Etiology and pathophysiology
 Venous disorders involve a problem with
transportation of blood back to the heart from the
capillary beds as a result of changes in smooth
muscle around vessels.
 Thrombophlebitis: inflammation of a vein associated with
clot formation; risk factors include immobilization, venous
stasis, vessel trauma, pregnancy, obesity and pelvic surgery
V Vascular disease: Thrombophlebitis, Varicose
veins and Peripheral Vascular Disease
Etiology and pathophysiology
 Venous disorders
 Varicose veins occur when veins in lower extremities
become dilated, congested, tortuous as a result of weakness
of valves or loss of elasticity of vessel walls. Risk factors
include family history, prolonged standing, leg trauma,
thrombophlebitis.
V Vascular disease: Thrombophlebitis, Varicose
veins and Peripheral Vascular Disease
Clinical Findings
 Peripheral arterial disorders
 Subjective: paresthesia; aching to severe or burning
pain
 Objective: pallor or cyanosis; gangrenous ulcers and
diminished pulses in Buergerǯs disease
V Vascular disease: Thrombophlebitis, Varicose
veins and Peripheral Vascular Disease
Clinical Findings
 Varicose veins
 Subjective: heaviness and fatigue in the legs with
cramping that increases at night
 Objective: positive venogram; brown skin
discoloration, stasis ulcers
V Vascular disease: Thrombophlebitis, Varicose
veins and Peripheral Vascular Disease
Clinical Findings
 Thrombophlebitis
 Subjective: pain on dorsiflexion of affected extremity
(Homanǯs sign); may be asymptomatic until embolus
is released and occludes organ.
 Objective: swollen limb with hard veins that are
sensitive to pressure; redness and warmth of area
along the vein.
V Vascular disease: Thrombophlebitis, Varicose
veins and Peripheral Vascular Disease
Therapeutic interventions
 Peripheral vascular disease
 Sympathectomy to sever the sympathetic ganglia supplying
the area; there is local vasodilation with improved
circulation
 Femoropopliteal bypass grafting
 Amputation
V Vascular disease: Thrombophlebitis, Varicose
veins and Peripheral Vascular Disease
Therapeutic interventions:
 Varicose veins
 Sclerotheraphy involves injection of a chemical irritant to
the vein.
 Surgical intervention through the ligation of the vein above
the varicosity and removal of the involved vein.
 Postoperative early ambulation is essential to prevent
formation of thrombi.
V Vascular disease: Thrombophlebitis, Varicose
veins and Peripheral Vascular Disease
Therapeutic interventions:
 Thrombophlebitis
 Prophylactic antiembolic stockings and exercises to
promote venous return
 Warm moist heat to promote vasodilation
 Elevation of extremity to reduce edema
 Anticoagulants to prevent recurrence of deep vein
involvement
 Vasodilators to prevent vascular spasm
V Vascular disease: Thrombophlebitis, Varicose
veins and Peripheral Vascular Disease
Therapeutic interventions:
 Thrombophlebitis
 Thrombolytic therapy to dissolve clot
V Vascular disease: Thrombophlebitis, Varicose
veins and Peripheral Vascular Disease
Nursing care:
Assessment:
 Risk factors and subjective data
 Affected extremity for pulses, color, temperature and

circumference
 Mobility of involved extremity
V Vascular disease: Thrombophlebitis, Varicose
veins and Peripheral Vascular Disease
Nursing care:
Diagnosis:
 Ineffective tissue perfusion: peripheral r/t venous
stasis
 Risk for impaired skin integrity r/t altered
peripheral tissue perfusion
 Chronic pain r/t vascular obstruction
V Vascular disease: Thrombophlebitis, Varicose
veins and Peripheral Vascular Disease
Nursing care:
Planning/Implementation
 Observe frequently for signs of vascular impairment
(pallor, cyanosis, coolness)
 Apply antiembolism stockings before ambulating
and remove and replace as ordered; if
thrombophlebitis is suspected maintain BR and
notify physician
V Vascular disease: Thrombophlebitis, Varicose
veins and Peripheral Vascular Disease
Nursing care:
Planning/Implementation
 Instruct the client to avoid tight and constrictive
clothing that can affect peripheral vessels, cigarette
smoking, massaging legs, maintaining one position
for long periods
 In arterial disease keep extremities warm; instruct to

wear gloves when exposed to cold


V Vascular disease: Thrombophlebitis, Varicose
veins and Peripheral Vascular Disease
Nursing care:
Planning/Implementation
 If undergoing surgery, monitor for hemorrhage,
assess circulatory status of extremity, keep extremity
elevated, allow out of bed as ordered.
 Following a vein ligation: elevate the foot of the bed
for the first 24 hours, observe for signs of
hemorrhage, maintain compression dressings, assist
with ambulation.
V Aneurysms
Etiology and Pathophysiology
 Distention at the site of a weakness in the arterial
wall.
 Saccular aneurysm: pouchlike projection on one side
of the artery.
 Fusiform aneurysm: entire circumference of the

artery wall is dilated.


 Mycotic aneurysm: tiny weaknesses in arterial walls
resulting from infection.
V Aneurysms
Etiology and Pathophysiology
 Dissecting aneurysm: tear in the inner lining of an
arteriosclerotic aortic wall causes blood to form a
hematoma between layers of the artery compressing
the lumen.
 Causes: congenital weakness; trauma;
atherosclerosis(common cause of both thoracic and
abdominal aneurysms)
 Surgical emergency if ruptured.
V Aneurysms
Etiology and Pathophysiology
 Occur most frequently in middle-aged white males
 Risk factors: history of hypertension, obesity, stress,

hypercholesterolemia, cigarette smoking, familial


tendency
V Aneurysms
Clinical Findings:
 Thoracic aortic aneurysm
 Subjective: may be asymptomatic; dyspnea; dysphagia; pain
resulting from pressure against the nerves or vertebrae
 Objective: hoarseness, cough and aphonia from
impingement on laryngeal nerve; unequal pulses and
arterial pressure in upper extremities; trachea may be
displaced from midline because of adhesions between
trachea and aneurysm.
V Aneurysms
Clinical Findings:
 Abdominal aortic aneurysm
 Subjective: may be asymptomatic; lower back or abdominal
pain (severe if aneurysm is leaking); sensory changes in the
lower extremities if aneurysm ruptures.
 Objective: hypertension; pulsating abdominal mass;
mottling of the lower extremities if aneurysm ruptures;
increased abdominal girth if aneurysm ruptures.
V Aneurysms
Clinical Findings:
 Dissecting aortic aneurysm
 Subjective: restlessness; anxiety; severe pain
 Objective: diminished pulses; signs of shock
V Aneurysms
Therapeutic Interventions
 Resection of the aneurysm and use of a Teflon or
Dacron graft
 If the aorta is involved the surgical procedure would
involve using a cardiopulmonary bypass
 Medical treatment is aimed at decreasing cardiac

output and blood pressure through the use of drugs.


V Aneurysms
Nursing care
 Assessment: History of risk factors, pulsation in
abdomen, history of pain

 Diagnosis:
 Ineffective tissue perfusion: peripheral r/t impaired
arterial circulation
 Risk for deficient fluid volume: hemorrhage r/t potential
blood loss
V Aneurysms
Nursing care
 Planning/Implementation
 Perform neurovascular assessment of extremities
 Monitor hemodynamic status
 Record intake and output, renal failure may occur after
surgery
 Administer narcotics as ordered to alleviate pain
 Apply abdominal binders to provide support when the
client is coughing, deep breathing and ambulating
 Prevent flexion of hip and knees to eliminate pressure on
the arterial wall.
V Shock
Etiology and Pathophysiology
 Hypovolemic: occurs when there is a loss of fluid
resulting in inadequate tissue perfusion; caused by
excessive bleeding, diarrhea, vomiting, fluid loss
from burns.
 Cardiogenic: occurs when pump failure causes

inadequate tissue perfusion; caused by heart failure;


myocardial infarction; cardiac tamponade.
V Shock
Etiology and Pathophysiology
 Neurogenic: caused by rapid vasodilation and
subsequent pooling of blood in the peripheral blood
vessels; caused by spinal anesthesia; emotional
stress; drugs that inhibit the SNS
 Anaphylactic: caused by an allergic reaction that

causes a release of histamine and subsequent


vasodilation.
 Septic: reaction to bacterial toxins (gram negative),

which results in the leakage of plasma into tissues


V Shock
Clinical Findings:
 Subjective: apprehension; restlessness; paresis of
extremities
 Objective: weak, rapid, thready pulse; diaphoresis;
cold; clammy skin; pallor; decreased urine output;
progressive loss of consciousness; decreased mean
arterial pressure.
V Shock
Therapeutic interventions
 Aimed at correcting the underlying cause
 Fluid and blood replacement

 O2 therapy, ventilator

 Vasoconstricting drugs to increase blood pressure

 Cardiac and hemodynamic monitoring

 Antihistamines for anaphylactic shock

 Cardiotonics for cardiogenic shock

 Antibiotics for septic shock


V Shock
Therapeutic interventions
 Elevation of lower extremities to ensure circulation
to vital organs.
V Shock
Nursing care
 Assessment: history of causative and risk factors
from client; fluid intake and output over the previous
24 hours; signs of covert bleeding: weak, thready
pulse; hypotension; increased respirations; cold
clammy skin.
V Shock
Nursing care
 Diagnosis:
 Ineffective tissue perfusion: cardiopulmonary r/t

arterial/venous blood flow exchange problems


 Risk for injury r/t prolonged shock resulting in
multiple organ failure
 Deficient fluid volume r/t loss of fluid
V Shock
Nursing care
 Planning/Implementation:
 Keep the client warm, place in supine position

 Monitor hemodynamic status and vital signs

 Monitor urine output and specific gravity

 Allay clientǯs anxiety

 Administer IV fluids as ordered

 Monitor O2 sat and provide O2 therapy as indicated.


V Anemias and Blood disorders
Etiology and Pathophysiology
 Iron deficiency anemia: most common cause is
bleeding r/t GI bleeding, menstruation; other causes
include inadequate dietary intake, malabsorption
and increased demand
 Folate deficiency: amount of folic acid absorbed or

ingested is insufficient to synthesize DNA, RNA and


proteins; associated with alcoholism, malabsorption,
pregnancy and lactation
V Anemias and Blood disorders
Etiology and Pathophysiology
 Pernicious anemia: lack of intrinsic factor in the
stomach prevents the absorption of Vit B12 which
reduces the number of erythrocytes formed.
 Aplastic anemia: bone marrow is depressed or
destroyed by a chemical or drug leading to
leukopenia, thrombocytopenia, decreased
erythrocytes and decreased leukocytes
(agranulocytosis)
V Anemias and Blood disorders
Etiology and Pathophysiology
 Hemolytic anemia: excessive or premature
destruction of red blood cells. There are many
causes which include sickle cell anemia, thalassemia,,
antibody reactions, infection and toxins.
 Polycythemia vera: a sustained increase in the

number of RBC, WBC, and platelets, with an


increased viscosity of the blood
V Anemias and Blood disorders
Etiology and Pathophysiology
 Thrombocytopenia purpura: appears to result from
the production of an antiplatelet antibody that coats
the surface of platelets and facilitates their
production by phagocytic leukocytes.
V Anemias and Blood disorders
Clinical Findings:
 Subjective: fatigue, headache; paresthesias; dyspnea;
sore mouth with pernicious anemia; gum bleeding
and epistaxis with thrombocytopenic purpura
 Objective: ankle edema, dry, pale mucous
membranes, pallor (except polycythemia vera),
decreased Hgb, RBC, ferritin, increased iron-binding
capacity, megaloblastic condition of the blood with
Fe-deficiency anemia, beefy red tongue, lack of
intrinsic factor, positive Romberg test with
pernicious anemia.
V Anemias and Blood disorders
Clinical Findings:
 Objective: Fever, bleeding from mucous membranes,
decreased WBC, RBC and platelets with aplastic
anemia, increased Hgb, purple-red complexion with
polycythemia vera, low platelet count, ecchymotic
areas, hemorrhagic petechiae with
thrombocytopenic purpura.
V Anemias and Blood disorders
Therapeutic interventions
 Improve diet: include ascorbic acid which stimulates
Fe uptake
 Vitamin supplements: iron, Vit B12, folic acid

 Blood transfusions (except for polycythemia vera)

 Corticosteroids and androgens to stimulate bone

marrow function; bone marrow transplant

You might also like